Thus, tamoxifen, a partial antagonist of the estrogen receptor, has beenlargely used for the treatment of estrogen receptor positive breast cancers, butresistance to this drug often occurs [22].The link between nutritional conditions, obesity and breast cancer is wellestablished, particularly in menopausal women [23]. This evidence concerns the gene ESR1 and obesity due to melanocortin 4 receptor deficiency.